$BRO

Brown&Brown earnings missed by $0.02, revenue fell short of estimates

Brown&Brown (BRO) reported Q3 EPS of $1.07, missing estimates by $0.02, with revenue at $1.72B, below the $1.76B consensus. The stock is up 0.30% over 3 months but down 19.01% year-over-year. InvestingPro rates its financial health as 'good performance'.

Original reporting
Published Oct 26, 2026, 9:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BRO
Bearish
high confidence
Mentioned
$BRO
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BROBearishMed
01

Why it matters

The miss could trigger short‑term selling pressure, especially in after‑hours trading.

02

Market read

Earnings miss is a primary catalyst for BRO's near‑term price movement.

03

What to watch

Management commentary on future guidance was not detailed in the article.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

Brown&Brown (NYSE: BRO) released its third‑quarter earnings, missing both EPS and revenue expectations.

Company-level read

Ticker impact

$BROBearishHigh confidence
Context

Brown&Brown reported Q3 EPS $1.07 vs $1.09 estimate and revenue $1.72B vs $1.76B estimate, a fresh earnings miss.

Expected impact

likely downside as market prices in the earnings miss

Evidence & confidence

Both EPS and revenue fell short of consensus, prompting investors to reassess guidance.

Market effects

May weigh on peers in the consumer services sector.

Limited to U.S. markets where BRO trades.

Low

Counterpoint

If the miss is already priced in, the stock could rebound on a positive outlook.

Key entities

  • Brown&Brown

    U.S. listed consumer services firm reporting Q3 results.

Related articles

$BROHighAI 8/10

Why Brown & Brown Stock Slumped by 5% Today

Brown & Brown (BRO) stock fell 5% after Q3 earnings missed estimates. Revenue rose 7% YoY to $1.73B, below the $1.76B consensus. GAAP net income increased 6% to $240M, while adjusted EPS grew 2% to $1.07, missing the $1.09 estimate. The company cited a challenging rate environment and attributed some growth to its Accession acquisition, but organic revenue grew only 1% YoY to $1.46B.

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.

$BROMed

Truist cuts Brown & Brown stock price target to $85 on lower estimates

Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.